Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.

Stocks | Futures | Watchlist | More
or

Ziopharm Oncology IN (ZIOP)

Ziopharm Oncology IN (ZIOP)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 482,776
  • Shares Outstanding, K 215,525
  • Annual Sales, $ 0 K
  • Annual Income, $ -79,980 K
  • 60-Month Beta 2.02
  • Price/Sales N/A
  • Price/Cash Flow N/A
  • Price/Book 4.56
Trade ZIOP with:

Options Overview

Details
  • Implied Volatility 112.47%
  • Historical Volatility 47.66%
  • IV Percentile 77%
  • IV Rank 27.87%
  • IV High 240.20% on 09/04/20
  • IV Low 63.13% on 05/25/21
  • Put/Call Vol Ratio 0.01
  • Today's Volume 538
  • Volume Avg (30-Day) 577
  • Put/Call OI Ratio 0.18
  • Today's Open Interest 49,312
  • Open Int (30-Day) 57,014

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 4 analysts offering recommendations.
Earnings Estimates - Current Qtr 06/30/21
See More
  • Average Estimate -0.14
  • Number of Estimates 3
  • High Estimate -0.11
  • Low Estimate -0.20
  • Prior Year -0.09
  • Growth Rate Est. (year over year) -55.56%

Price Performance

See More
Period Period Low Period High Performance
1-Month
2.15 +5.34%
on 07/27/21
2.75 -17.45%
on 07/02/21
-0.45 (-16.54%)
since 06/28/21
3-Month
2.15 +5.34%
on 07/27/21
3.73 -39.14%
on 06/09/21
-1.24 (-35.33%)
since 04/28/21
52-Week
2.06 +10.19%
on 10/30/20
5.95 -61.85%
on 02/10/21
-0.75 (-24.83%)
since 07/28/20

Most Recent Stories

More News
Ziopharm Oncology to Report Second Quarter Financial Results on August 9, 2021

Ziopharm Oncology, Inc. (Nasdaq: ZIOP), today announced that management will host a conference call and webcast on Monday, August 9, at 4:30 p.m. EDT to provide a corporate update and discuss financial...

ZIOP : 2.27 (+1.34%)
Ziopharm Oncology to Participate in Upcoming Conferences

Ziopharm Oncology, Inc. ("Ziopharm" or the "Company") (Nasdaq: ZIOP), a clinical-stage cellular therapy company focused on hematologic and solid tumor cancers, today announced that Company management will...

ZIOP : 2.27 (+1.34%)
Ziopharm Oncology Reinforces Clear and Bold Vision for Delivering Value at Annual Shareholders Meeting

- Highlighted distinctive cellular therapy program, market opportunity and value proposition

ZIOP : 2.27 (+1.34%)
Ziopharm: Q1 Earnings Snapshot

BOSTON (AP) _ Ziopharm Oncology Inc. (ZIOP) on Thursday reported a loss of $21.6 million in its first quarter.

ZIOP : 2.27 (+1.34%)
Ziopharm Oncology Reports First Quarter 2021 Financial Results and Provides Corporate Updates

- Annual shareholder meeting planned for May 19, 2021

ZIOP : 2.27 (+1.34%)
ZIOPHARM Oncology, Inc. to Host Earnings Call

NEW YORK, NY / ACCESSWIRE / May 6, 2021 / ZIOPHARM Oncology, Inc. (NASDAQ:ZIOP) will be discussing their earnings results in their 2021 First Quarter Earnings call to be held on May 6, 2021 at 4:30 PM...

ZIOP : 2.27 (+1.34%)
Ziopharm Oncology Scientific Advisor Laurence Cooper, MD, PhD, to Present at University of Pennsylvania Cellicon Valley '21 Two-Day Live Virtual Educational Symposium

Ziopharm Oncology, Inc. ("Ziopharm" or the "Company") (Nasdaq: ZIOP), announced today that Laurence J.N. Cooper, PhD, MD, Scientific Advisor to the Company, will present and participate in an upcoming...

ZIOP : 2.27 (+1.34%)
Ziopharm Oncology to Report First Quarter Financial Results on May 6, 2021

Ziopharm Oncology, Inc. (Nasdaq: ZIOP), today announced it will report first quarter 2021 financial results on Thursday, May 6, 2021 after the financial markets close, and host its annual shareholder meeting...

ZIOP : 2.27 (+1.34%)
Ziopharm Oncology Scientific Advisor Laurence J. N. Cooper, PhD, MD, Presented Today at Aldevron's Virtual Breakthrough Speakers Series

Ziopharm Oncology, Inc. ("Ziopharm" or the "Company") (Nasdaq: ZIOP), announced today that Laurence J.N. Cooper, PhD, MD, Scientific Advisor to the Company, was the inaugural presenter at Aldevron's Virtual...

ZIOP : 2.27 (+1.34%)
Ziopharm Oncology Announces First Patient Infused in CD19 RPM CAR-T Phase I Clinical Trial Being Conducted by Joint Venture Partner Eden BioCell

Ziopharm Oncology, Inc. ("Ziopharm" or the "Company") (Nasdaq: ZIOP), announced today that in March, the first patient was infused in the CD19-Specific Rapid Personalized Manufacturing ("RPM") CAR-T Phase...

ZIOP : 2.27 (+1.34%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 100% Sell with a Strengthening short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

The market is approaching oversold territory. Be watchful of a trend reversal.

See More Share

Business Summary

ZIOPHARM Oncology, Inc. is a biopharmaceutical company engaged in the development and commercialization of a diverse, risk-sensitive portfolio of in-licensed cancer drugs to address unmet medical needs. The Company applies new insights from molecular and cancer biology to understand the efficacy and...

See More

Key Turning Points

3rd Resistance Point 2.49
2nd Resistance Point 2.42
1st Resistance Point 2.34
Last Price 2.27
1st Support Level 2.19
2nd Support Level 2.12
3rd Support Level 2.04

See More

52-Week High 5.95
Fibonacci 61.8% 4.46
Fibonacci 50% 4.01
Fibonacci 38.2% 3.55
Last Price 2.27
52-Week Low 2.06

See More

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar